Ignite Creation Date:
2025-12-24 @ 9:12 PM
Ignite Modification Date:
2026-02-03 @ 2:56 AM
Study NCT ID:
NCT04466904
Status:
COMPLETED
Last Update Posted:
2021-07-23
First Post:
2020-07-01
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Multiple-dose Tolerability and Pharmacokinetic of IBI362 in Chinese Patients With T2DM
Sponsor:
Innovent Biologics (Suzhou) Co. Ltd.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Type 2 Diabetes | View |
Keywords: